Clinical trial
Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of…
NCT00125463 · The Japanese Society of Hypertension, Other · Unknown status
Key facts
| NCT number | NCT00125463 |
|---|---|
| Title | Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients |
| Official title | Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients |
| Lead sponsor | The Japanese Society of Hypertension, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension, Cardiovascular Diseases |
| Intervention type | Drug |
| Interventions | Candesartan cilexetil |
| Enrollment | 3,200 |
| Start date | Sep 1, 2001 |
| Completion | Dec 1, 2005 |
| First posted | Aug 1, 2005 |
| Last update posted | Aug 10, 2005 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: